International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지
DOI QR코드

DOI QR Code

Apelin-APJ axis inhibits TNF-alpha-mediated expression of genes involved in the inflammatory response in periodontal ligament cells

  • Lee, Gyuseok (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University) ;
  • Song, Won-Hyun (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University) ;
  • Kim, Su-Jin (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University) ;
  • Kim, Young-Gwon (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University) ;
  • Ryu, Je-Hwang (Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University)
  • Received : 2019.11.11
  • Accepted : 2019.12.18
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Periodontitis is an inflammatory disease of the supportive tissues surrounding the teeth, and is characterized by irreversible destruction of the gingiva, periodontal ligament (PDL), and alveolar bone, which results in the loss of teeth. In the present study, we elucidated the correlation between periodontitis and apelin (APLN), an adipokine and a regulatory peptide, respectively, which are involved in inflammation and bone remodeling. The expression of APLN is negatively correlated with periodontitis progression in gingival tissue. In addition, treatment with TNF-α downregulated the expression of APLN in PDL cells and gingival fibroblasts, indicating the protective role played by APLN against periodontitis progression. The overexpression of APLN or treatment with exogenous APLN suppressed the TNF-α-mediated catabolic gene expression of MMP1, IL6, and PTGS2 in PDL cells. Moreover, the inhibition of the APLNA-PJ axis by ML221, an APJ inhibitor, induced catabolic gene expression in PDL cells. Thus, the results of this study provided evidence to support APLN as a regulatory factor of the inflammatory response during periodontitis.

Keywords

References

  1. Flemmig TF. Periodontitis. Ann Periodontol 1999;4:32-8. doi:10.1902/annals.1999.4.1.32.
  2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-20. doi: 10.1016/S0140-6736(05)67728-8.
  3. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015;15: 30-44. doi: 10.1038/nri3785.
  4. Scheres N, Laine ML, Sipos PM, Bosch-Tijhof CJ, Crielaard W, de Vries TJ, et al. Periodontal ligament and gingival fibroblasts from periodontitis patients are more active in interaction with Porphyromonas gingivalis. J Periodontal Res 2011;46:407-16. doi: 10.1111/j.1600-0765.2011.01353.x.
  5. Franco C, Patricia HR, Timo S, Claudia B, Marcela H. Matrix metalloproteinases as regulators of periodontal inflammation. Int J Mol Sci 2017;18:E440. doi: 10.3390/ijms18020440.
  6. Herath TD, Wang Y, Seneviratne CJ, Darveau RP, Wang CY, Jin L. The expression and regulation of matrix metalloproteinase-3 is critically modulated by Porphyromonas gingivalis lipopolysaccharide with heterogeneous lipid A structures in human gingival fibroblasts. BMC Microbiol 2013;13:73. doi:10.1186/1471-2180-13-73.
  7. Tiranathanagul S, Yongchaitrakul T, Pattamapun K, Pavasant P. Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells. J Periodontol 2004;75:1647-54. doi: 10.1902/jop.2004.75.12.1647.
  8. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014;64:57-80. doi: 10.1111/prd.12002.
  9. Di Benedetto A, Gigante I, Colucci S, Grano M. Periodontal disease: linking the primary inflammation to bone loss. Clin Dev Immunol 2013;2013:503754. doi: 10.1155/2013/503754.
  10. Hienz SA, Paliwal S, Ivanovski S. Mechanisms of bone resorption in periodontitis. J Immunol Res 2015;2015:615486. doi: 10.1155/2015/615486.
  11. Borgnakke WS, Ylostalo PV, Taylor GW, Genco RJ. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Periodontol 2013;84(4 Suppl):S135-52. doi: 10.1902/jop.2013.1340013.
  12. Martin-Cabezas R, Seelam N, Petit C, Agossa K, Gaertner S, Tenenbaum H, et al. Association between periodontitis and arterial hypertension: a systematic review and meta-analysis. Am Heart J 2016;180:98-112. doi: 10.1016/j.ahj.2016.07.018.
  13. Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 2003;8:38-53. doi: 10.1902/annals.2003.8.1.38.
  14. Borawski J, Wilczynska-Borawska M, Stokowska W, Mysliwiec M. The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients. Nephrol Dial Transplant 2007;22:457-64. doi: 10.1093/ndt/gfl676.
  15. Fisher MA, Borgnakke WS, Taylor GW. Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr Opin Nephrol Hypertens 2010;19:519-26. doi:10.1097/MNH.0b013e32833eda38.
  16. Chambrone L, Foz AM, Guglielmetti MR, Pannuti CM, Artese HP, Feres M, Romito GA. Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. J Clin Periodontol 2013;40:443-56. doi:10.1111/jcpe.12067.
  17. Abbayya K, Puthanakar NY, Naduwinmani S, Chidambar YS. Association between periodontitis and Alzheimer's disease. N Am J Med Sci 2015;7:241-6. doi: 10.4103/1947-2714.159325.
  18. Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, Fuller J, Ibbett P, Raybould R, Thomas R, Puenter U, Teeling J, Perry VH, Holmes C. Periodontitis and cognitive decline in Alzheimer's disease. PLoS One 2016;11:e0151081. doi:10.1371/journal.pone.0151081.
  19. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 2007;34:931-7. doi: 10.1111/j.1600-051X.2007.01133.x.
  20. Furugen R, Hayashida H, Kitamura M, Saito T. Relationship between adipokines and periodontitis. Jap Dent Sci Rev 2010;46:159-64. doi: 10.1016/j.jdsr.2010.01.001.
  21. Deschner J, Eick S, Damanaki A, Nokhbehsaim M. The role of adipokines in periodontal infection and healing. Mol Oral Microbiol 2014;29:258-69. doi: 10.1111/omi.12070.
  22. Kim D, Lee G, Huh YH, Lee SY, Park KH, Kim S, Kim J, Koh J, Ryu J. NAMPT is an essential regulator of RA-mediated periodontal inflammation. J Dent Res 2017;96:703-11. doi:10.1177/0022034517690389.
  23. Park KH, Kim DK, Huh YH, Lee G, Lee SH, Hong Y, Kim SH, Kook MS, Koh JT, Chun JS, Lee SE, Ryu JH. NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis. Exp Mol Med 2017;49:e368. doi:10.1038/emm.2017.116.
  24. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR, Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136:355-60. doi: 10.1016/0378-1119(93)90495-o.
  25. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005;146:1764-71. doi: 10.1210/en.2004-1427.
  26. Xie H, Tang SY, Cui RR, Huang J, Ren XH, Yuan LQ, Lu Y, Yang M, Zhou HD, Wu XP, Luo XH, Liao EY. Apelin and its receptor are expressed in human osteoblasts. Regul Pept 2006;134:118-25. doi: 10.1016/j.regpep.2006.02.004.
  27. Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Guo LJ, Zhou HD, Wu XP, Liao EY. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007;12:247-54. doi: 10.1007/s10495-006-0489-7.
  28. Shan PF, Lu Y, Cui RR, Jiang Y, Yuan LQ, Liao EY. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells. PLoS One 2011;6:e17938. doi: 10.1371/journal.pone.0017938.
  29. Hang K, Ye C, Xu J, Chen E, Wang C, Zhang W, Ni L, Kuang Z, Ying L, Xue D, Pan Z. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/${\beta}$-catenin signaling pathway. Stem Cell Res Ther 2019;10:189. doi: 10.1186/s13287-019-1286-x.
  30. Wattanachanya L, Lu WD, Kundu RK, Wang L, Abbott MJ, O'Carroll D, Quertermous T, Nissenson RA. Increased bone mass in mice lacking the adipokine apelin. Endocrinology 2013;154:2069-80. doi: 10.1210/en.2012-2034.
  31. Zhou Q, Cao J, Chen L. Apelin/APJ system: a novel therapeutic target for oxidative stress-related inflammatory diseases (Review). Int J Mol Med 2016;37:1159-69. doi: 10.3892/ijmm.2016.2544.
  32. Moon JS, Cheong NR, Yang SY, Kim IS, Chung HJ, Jeong YW, Park JC, Kim MS, Kim SH, Ko HM. Lipopolysaccharideinduced indoleamine 2,3-dioxygenase expression in the periodontal ligament. J Periodontal Res 2013;48:733-9. doi:10.1111/jre.12063.
  33. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS, Valet P, Castan-Laurell I. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 2006;20:1528-30. doi: 10.1096/fj.05-5243fje.
  34. Xin Q, Cheng B, Pan Y, Liu H, Yang C, Chen J, Bai B. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides 2015; 63:55-62. doi: 10.1016/j.peptides.2014.09.016.
  35. Han S, Englander EW, Gomez GA, Greeley GH Jr. Apelin regulates nuclear factor-${\kappa}B$'s involvement in the inflammatory response of pancreatitis. Pancreas 2017;46:64-70. doi:10.1097/MPA.0000000000000740.
  36. Chen L, Tao Y, Jiang Y. Apelin activates the expression of inflammatory cytokines in microglial BV2 cells via PI-3K/Akt and MEK/Erk pathways. Sci China Life Sci 2015;58:531-40. doi: 10.1007/s11427-015-4861-0.
  37. Li L, Li F, Li F, Mao X, Yang L, Huang H, Guo Y, Chen L, Li J. NOX4-derived reactive oxygen species drive apelin-13-induced vascular smooth muscle cell proliferation via the ERK pathway. Int J Pept Res Ther 2011;17:307-15. doi: 10.1007/s10989-011-9269-5.
  38. Lu Y, Zhu X, Liang GX, Cui RR, Liu Y, Wu SS, Liang QH, Liu GY, Jiang Y, Liao XB, Xie H, Zhou HD, Wu XP, Yuan LQ, Liao EY. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-${\kappa}B$/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 2012;43:2125-36. doi:10.1007/s00726-012-1298-7.